Literature DB >> 788526

Uptake of bile acids by perfused rat liver.

J Reichen, G Paumgartner.   

Abstract

The uptake of 14C-labeled cholic, taurocholic, and chenodeoxycholic acid by the perfused rat liver was studied to characterize the mechanism responsible for hepatic uptake of bile acids. A rapid-injection multiple indicator-dilution technique and the three-compartment model of Goresky were employed. The kinetics of hepatic uptake of the three bile acids could be described by the Michaelis-Menten equation. The maximal uptake velocities (Vmax) were 24.9 +/- 2.2 (mean +/- SD), 20.8 +/- 1.2, 1.2, and 11.4 +/- 0.9 nmol/s-g liver for cholic, taurocholic, and chenodeoxycholic acid, respectively. The corresponding apparent half-saturation constants (Km) were 526 +/- 125, 258 +/- 43, and 236 +/- 48 nmol/g liver. Competitive inhibition could be demonstrated between cholate and taurocholate as well as between cholate and chenodeoxycholate. Substitution of 94% of the Na+ in the perfusion medium decreased the Vmax and the apparent Km of taurocholate uptake by 68 and 55%, respectively. These findings are consistent with the hypothesis that bile acids are taken up into the hepatocyte by Na+-dependent carrier-mediated transport.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788526     DOI: 10.1152/ajplegacy.1976.231.3.734

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  50 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.

Authors:  Y B Chung; S Miyauchi; Y Sugiyama; H Harashima; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

3.  Bile duct ligation-induced redistribution of canalicular antigen in rat hepatocyte plasma membranes demonstrated by immunogold quantitation.

Authors:  L Landmann; P J Meier; L Bianchi
Journal:  Histochemistry       Date:  1990

4.  The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.

Authors:  Brandy Garzel; Hui Yang; Lei Zhang; Shiew-Mei Huang; James E Polli; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2013-12-12       Impact factor: 3.922

5.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

6.  Bile acid excretion: the alternate pathway in the hamster.

Authors:  R Galeazzi; N B Javitt
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

7.  Hepatic microcirculation in the perfused cirrhotic rat liver.

Authors:  F Varin; P M Huet
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

8.  [Pathogenic significance of bile acids (author's transl)].

Authors:  W Gerok; S Matern
Journal:  Klin Wochenschr       Date:  1981-06-15

9.  Physiological factors influencing serum bile acid levels.

Authors:  M Ponz De Leon; G M Murphy; R H Dowling
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

10.  Inhibition of hepatic uptake of bile acids by rifamycins.

Authors:  M S Anwer; R Kroker; D Hegner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.